Lattice Semiconductor
LSCC Nasdaq Semiconductors Financials FY2016βFY2025
Lattice Semiconductor's revenue rose 2.7% to $523 million in fiscal 2025. Its operating margin was 2.1%, down from 6.8% a year earlier. Free cash flow was $133 million, up 10.6%. It paid out $100 million in dividends and buybacks, 75% of free cash flow.
What Lattice Semiconductor does
No business description yet.
- Legal name
- LATTICE SEMICONDUCTOR CORP
- Fiscal year ends
- January 3, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001437749-26-004100
0000855658
Revenue and margins
Lattice Semiconductor had $523M of revenue in fiscal 2025, up 2.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $133M in fiscal 2025, 25.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Lattice Semiconductor returned $100M to shareholders in fiscal 2025, 75% of free cash flow. The diluted share count fell 0.1%.
Value Lattice Semiconductor yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $134M and divides by 138.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today β Β· peers 30.9x Β· sector 33.3x.
Balance sheet
Cash, debt and the ratios that show how comfortably Lattice Semiconductor can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $132M | $146M | $128M | $136M | $134M |
| Debt incl. finance leases | $159M | $129M | $0.0M | $0.0M | $0.0M |
| Net debt / EBITDA | 0.2x | β0.1x | β0.6x | β2.3x | β4.0x |
| Debt / equity | 0.4x | 0.3x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 36.8x | 45.2x | 71.5x | 129.5x | 42.6x |
| Current ratio | 2.8x | 3.0x | 3.8x | 3.7x | 3.1x |
| Quick ratio | 2.2x | 2.1x | 2.8x | 2.6x | 2.3x |
| Total assets | $727M | $799M | $841M | $844M | $883M |
| Total liabilities | $315M | $312M | $149M | $133M | $169M |
| Shareholders' equity | $412M | $487M | $692M | $711M | $714M |
| Net debt (β = net cash) | $27.2M | β$16.9M | β$128M | β$136M | β$134M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$7.5M
7 insiders
Of sales under plans
76%
$5.6M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Pravin DesaleSVP, R&D | Sold plan | 4,279 | $105.62 | $0.5M | Form 4 |
| Sep 14, 2026 | Pravin DesaleSVP, R&D | Sold plan | 2,039 | $111.83 | $0.2M | Form 4 |
| Aug 18, 2026 | Tracy Ann FeannySVP, General Counsel | Sold plan | 1,880 | $126.43 | $0.2M | Form 4 |
| Aug 17, 2026 | Esam ElashmawiSVP, Strategy and Marketing | Sold plan | 15,742 | $134.77 | $2.1M | Form 4 |
| Jun 12, 2026 | Pravin DesaleSVP, R&D | Sold plan | 2,039 | $142.89 | $0.3M | Form 4 |
| Jun 4, 2026 | Tracy Ann FeannySVP, General Counsel | Sold plan | 2,740 | $151.84 | $0.4M | Form 4 |
| Jun 3, 2026 | James P LedererDirector | Sold | 6,101 | $153.94 | $0.9M | Form 4 |
| May 20, 2026 | Pravin DesaleSVP, R&D | Sold plan | 14,155 | $134.23 | $1.9M | Form 4 |
| May 6, 2026 | Elizabeth M SchwartingDirector | Sold | 3,200 | $124.53 | $0.4M | Form 4 |
| Mar 11, 2026 | Tonya StevensCvp, Chief Accounting Officer | Sold | 1,113 | $94.00 | $0.1M | Form 4 |
| Mar 10, 2026 | Erhaan ShaikhSVP, Sales | Sold | 1,577 | $93.33 | $0.1M | Form 4 |
| Mar 10, 2026 | Pravin DesaleSVP, R&D | Sold | 2,366 | $92.41 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 9 / 9 | 4 / 9 | 6 / 9 |
| Accruals ratio | β1.3% | β9.5% | β19.9% |
| Altman Z'' | 9.26 | 8.76 | 7.13 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Lattice Semiconductor LSCC | $13.5B | 2.7% | 2.2% | 25.3% | 1.0% | β | 6 | |
| Universal Display OLED | $4.1B | 0.5% | 38.2% | 23.7% | 17.9% | 21.0x | 3 | Compare β |
| Rambus RMBS | $9.4B | 27.1% | 36.8% | 47.1% | 34.3% | 40.8x | 5 | Compare β |
| Silicon Labs SLAB | $7.3B | 34.3% | β9.0% | 8.4% | β7.0% | β | 5 | Compare β |
| SiTime SITM | $12.7B | 61.2% | β20.5% | 10.8% | β16.8% | β | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $427M | $386M | $399M | $404M | $408M | $515M | $660M | $737M | $509M | $523M |
| Gross profit | $247M | $217M | $219M | $238M | $245M | $322M | $452M | $515M | $340M | $357M |
| Research and development | $118M | $103M | $82.4M | $78.6M | $89.2M | $111M | $136M | $160M | $159M | $188M |
| Operating income | β$26.7M | β$47.6M | β$3.1M | $59.0M | $52.4M | $101M | $187M | $212M | $34.5M | $11.2M |
| Interest expense | $20.3M | $18.8M | $20.6M | $11.7M | $3.7M | $2.7M | $4.1M | $3.0M | $0.3M | $0.3M |
| Pretax income | β$44.2M | β$69.7M | β$24.0M | $45.1M | $48.5M | $97.6M | $182M | $215M | $36.2M | $13.4M |
| Income tax | $9.9M | $0.8M | $2.4M | $1.6M | $1.1M | $1.7M | $3.2M | β$44.2M | β$24.9M | $10.3M |
| Net income | β$54.1M | β$70.6M | β$26.3M | $43.5M | $47.4M | $95.9M | $179M | $259M | $61.1M | $3.1M |
| Diluted EPS | β$0.45 | β$0.58 | β$0.21 | $0.32 | $0.34 | $0.67 | $1.27 | $1.85 | $0.44 | $0.02 |
| Diluted shares | 0.12B | 0.12B | 0.13B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B |
| Cash flow | ||||||||||
| Cash from operations | $41.7M | $38.5M | $51.5M | $124M | $91.7M | $168M | $239M | $270M | $141M | $175M |
| Capital expenditure | $16.7M | $12.9M | $8.4M | $15.6M | $12.1M | $9.8M | $23.3M | $20.1M | $21.0M | $42.5M |
| Free cash flow | $25.0M | $25.7M | $43.1M | $109M | $79.6M | $158M | $215M | $249M | $120M | $133M |
| Depreciation and amortization | $61.8M | $57.9M | $39.3M | $33.1M | $16.4M | $15.5M | $18.6M | $21.9M | $24.0M | $22.1M |
| Stock-based compensation | $16.2M | $12.5M | $13.6M | $18.9M | $40.4M | $46.5M | $55.5M | $70.2M | $53.0M | $116M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $68.1M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $15.0M | $70.1M | $110M | $80.0M | $67.0M | $100M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $15.0M | $70.1M | $110M | $80.0M | $67.0M | $100M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $107M | $112M | $127M | $118M | $182M | $132M | $146M | $128M | $136M | $134M |
| Total debt | $335M | $301M | $251M | $125M | $172M | $159M | $129M | $0.0M | $0.0M | $0.0M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $315M | $263M | $284M | $262M | $334M | $301M | $379M | $368M | $365M | $364M |
| Current liabilities | $158M | $83.6M | $69.4M | $99.8M | $79.7M | $106M | $127M | $97.4M | $99.6M | $118M |
| Inventory | $79.2M | $79.9M | $67.1M | $55.0M | $64.6M | $67.6M | $110M | $98.8M | $103M | $89.2M |
| Property and equipment, net | $49.5M | $40.4M | $34.9M | $39.2M | $39.7M | $38.1M | $47.6M | $49.5M | $53.0M | $77.0M |
| Total assets | $767M | $636M | $624M | $612M | $680M | $727M | $799M | $841M | $844M | $883M |
| Total liabilities | $497M | $418M | $365M | $284M | $296M | $315M | $312M | $149M | $133M | $169M |
| Shareholders' equity | $270M | $245M | $259M | $328M | $384M | $412M | $487M | $692M | $711M | $714M |
| Margins | ||||||||||
| Gross margin | 57.9% | 56.1% | 55.0% | 59.0% | 60.1% | 62.4% | 68.5% | 69.8% | 66.8% | 68.2% |
| Operating margin | β6.3% | β12.3% | β0.8% | 14.6% | 12.8% | 19.6% | 28.4% | 28.8% | 6.8% | 2.2% |
| EBITDA margin | 8.2% | 2.7% | 9.1% | 22.8% | 16.8% | 22.6% | 31.2% | 31.8% | 11.5% | 6.4% |
| Net margin | β12.7% | β18.3% | β6.6% | 10.8% | 11.6% | 18.6% | 27.1% | 35.1% | 12.0% | 0.6% |
| FCF margin | 5.9% | 6.7% | 10.8% | 26.9% | 19.5% | 30.6% | 32.6% | 33.9% | 23.5% | 25.3% |
| Returns | ||||||||||
| Return on capital | β4.0% | β8.1% | β0.6% | 15.9% | 14.5% | 24.4% | 40.5% | 41.1% | 6.1% | 1.0% |
| Return on capital employed | β4.2% | β8.2% | β0.6% | 11.1% | 9.4% | 16.5% | 29.0% | 30.0% | 4.6% | 1.5% |
| Return on equity | β18.8% | β27.4% | β10.5% | 14.8% | 13.3% | 24.1% | 39.8% | 43.9% | 8.7% | 0.4% |
| Return on assets | β7.0% | β10.1% | β4.2% | 7.0% | 7.3% | 13.6% | 23.5% | 31.6% | 7.3% | 0.4% |
| Growth | ||||||||||
| Revenue growth | 5.2% | β9.6% | 3.3% | 1.3% | 1.0% | 26.3% | 28.1% | 11.6% | β30.9% | 2.7% |
| Net income growth | β | β | β | β | 9.0% | 102.4% | 86.5% | 44.8% | β76.4% | β95.0% |
| EPS growth | β | β | β | β | 6.3% | 97.1% | 89.6% | 45.7% | β76.2% | β95.5% |
| FCF growth | β | 2.6% | 67.9% | 152.0% | β26.7% | 98.4% | 36.5% | 15.8% | β52.0% | 10.6% |
| Share count change | 2.2% | 2.2% | 3.2% | 8.5% | 2.9% | 0.6% | β1.0% | β0.6% | β1.1% | β0.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 6.5x | 18.5x | 3.5x | 0.1x | β0.2x | 0.2x | β0.1x | β0.6x | β2.3x | β4.0x |
| Debt / equity | 1.2x | 1.2x | 1.0x | 0.4x | 0.5x | 0.4x | 0.3x | 0.0x | 0.0x | 0.0x |
| Interest coverage | β1.3x | β2.5x | β0.2x | 5.0x | 14.2x | 36.8x | 45.2x | 71.5x | 129.5x | 42.6x |
| Current ratio | 2.0x | 3.2x | 4.1x | 2.6x | 4.2x | 2.8x | 3.0x | 3.8x | 3.7x | 3.1x |
| Quick ratio | 1.5x | 2.2x | 3.1x | 2.1x | 3.4x | 2.2x | 2.1x | 2.8x | 2.6x | 2.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.9% | 3.3% | 2.1% | 3.9% | 3.0% | 1.9% | 3.5% | 2.7% | 4.1% | 8.1% |
| Stock comp / revenue | 3.8% | 3.3% | 3.4% | 4.7% | 9.9% | 9.0% | 8.4% | 9.5% | 10.4% | 22.1% |
| Payouts / FCF | 0.0% | 0.0% | 0.0% | 0.0% | 18.8% | 44.4% | 51.1% | 32.1% | 55.9% | 75.4% |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 4.0 | 6.0 | 7.0 | 7.0 | 7.0 | 9.0 | 9.0 | 4.0 | 6.0 |
| Altman Z'' | β0.1 | β0.5 | 0.5 | 1.3 | 2.5 | 2.8 | 4.8 | 9.3 | 8.8 | 7.1 |
| Accruals ratio | β12.3% | β15.6% | β12.4% | β13.1% | β6.9% | β10.2% | β7.9% | β1.3% | β9.5% | β19.9% |
Source: SEC EDGAR XBRL filings (CIK 0000855658). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.